Sethera Therapeutics Appoints Jeffery W. Kelly and Alexander M. Klibanov to Scientific Advisory Board
SALT LAKE CITY, UT, UNITED STATES, September 25, 2025 /EINPresswire.com/ -- Sethera Therapeutics, a biotechnology company advancing next-generation polymacrocyclic peptide therapeutics, today announced the appointment of two globally recognized …